Hain Celestial Reports First Quarter Fiscal Year 2021 Financial Results
FINANCIAL HIGHLIGHTS1
Summary of First Quarter Results from Continuing Operations2
- Net sales increased 3% to
$498.6 million , or 1% on a constant currency basis, compared to the prior year period. - When adjusted to exclude the effects of foreign exchange, divestitures and discontinued brands, net sales increased 5% compared to the prior year period.
- Gross margin of 23.9%, a 360 basis point increase from the prior year period.
- Adjusted gross margin of 24.1%, a 326 basis point increase from the prior year period.
- Operating income of
$3.3 million compared to$2.5 million in the prior year period. - Adjusted operating income of
$38.8 million compared to$16.9 million in the prior year period. - Net loss of
$10.8 million primarily driven by theUnited Kingdom fruit business impairment of$32.5 million compared to$5.0 million in the prior year period. - Adjusted net income of
$27.4 million compared to$8.4 million in prior year period. - Adjusted EBITDA of
$54.9 million compared to$32.1 million in the prior year period. - Adjusted EBITDA margin of 11.0%, a 435 basis point increase compared to the prior year period.
- Loss per diluted share of
$0.11 compared to$0.05 in the prior year period. - Adjusted earnings per diluted share ("EPS") of
$0.27 compared to$0.08 in the prior year period. - Repurchased 1.3 million shares, or 1.3% of the outstanding common stock, at an average price of
$32.81 per share. - Net cash provided by continuing operations of
$40.7 million compared to net cash used in continuing operations of$3.6 million in prior year period. - Operating free cash flow from continuing operations of
$28.5 million compared to negative operating free cash flow of$16.7 million in prior year period.
1 This press release includes certain non-GAAP financial measures, which are intended to supplement, not substitute for, comparable GAAP financial measures. Reconciliations of non-GAAP financial measures to GAAP financial measures and other non-GAAP financial calculations are provided herein in the tables. |
|||
2 Unless otherwise noted all results included in this press release are from continuing operations. |
SEGMENT HIGHLIGHTS FROM CONTINUING OPERATIONS
The Company operates under two reportable segments:
Segment gross profit in the first quarter was
Segment operating income in the first quarter was
Adjusted EBITDA in the first quarter was
International
International net sales in the first quarter were
Segment gross profit in the first quarter was
Segment operating loss in the first quarter was
Adjusted EBITDA in the first quarter was
CAPITAL MANAGEMENT
During the first quarter fiscal year 2021, the Company repurchased 1.3 million shares, or 1.3% of the outstanding common stock, at an average price of
FISCAL YEAR 2021 GUIDANCE
The Company reaffirms its expectation for gross and adjusted EBITDA margin expansion as well as strong double-digit adjusted EBITDA and operating free cash flow growth for fiscal year 2021. Due to the continuing uncertainty around the duration and impact of the COVID-19 pandemic, the Company is not providing specific financial guidance for fiscal year 2021. However, for second quarter fiscal year 2021, the Company expects mid-single digit topline growth (on a constant currency basis adjusted for divestitures and discontinued brands) with several hundred basis points of gross margin improvement and adjusted EBITDA growth similar to the growth in the second half of prior year.
Webcast Presentation
About
Safe Harbor Statement
Certain statements contained in this press release constitute "forward-looking statements" within the meaning of federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictions based on expectations and projections about future events and are not statements of historical fact. You can identify forward-looking statements by the use of forward-looking terminology such as "plan", "continue", "expect", "anticipate", "intend", "predict", "project", "estimate", "likely", "believe", "might", "seek", "may", "will", "remain", "potential", "can", "should", "could", "future" and similar expressions, or the negative of those expressions, or similar words or phrases that are predictions of or indicate future events or trends and that do not relate solely to historical matters. You can also identify forward-looking statements by discussions of the Company's strategic initiatives, including productivity and transformation, the Company's guidance for fiscal year 2021 and our future performance and results of operations.
Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, levels of activity, performance or achievements of the Company, or industry results, to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements, and you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data or methods that may be incorrect or imprecise and may not be able to be realized. We do not guarantee that the transactions and events described will happen as described (or that they will happen at all). Such factors include, among others, challenges and uncertainty resulting from the COVID-19 pandemic, the impact of competitive products and changes to the competitive environment, changes to consumer preferences, general economic and financial market conditions, the
Non-GAAP Financial Measures
This press release and the accompanying tables include non-GAAP financial measures, including adjusted operating income and its related margin, adjusted gross margin, adjusted net income, adjusted earnings per diluted share, net sales adjusted for the impact of foreign exchange, divestitures and discontinued brands, adjusted EBITDA and its related margin and operating free cash flow. The reconciliations of these non-GAAP financial measures to the comparable GAAP financial measures are provided herein in the tables. Management believes that the non-GAAP financial measures presented provide useful additional information to investors about current trends in the Company's operations and are useful for period-over-period comparisons of operations. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. They should be read only in connection with the Company's Consolidated Statements of Operations presented in accordance with GAAP.
The Company believes presenting net sales at constant currency provides useful information to investors because it provides transparency to underlying performance in the Company's consolidated net sales by excluding the effect that foreign currency exchange rate fluctuations have on period-to-period comparability given the volatility in foreign currency exchange markets. To present this information for historical periods, current period net sales for entities reporting in currencies other than the
The Company provides net sales adjusted for the impact of foreign currency, divestitures and discontinued brands to understand the growth rate of net sales excluding the impact of such items. The Company's management believes net sales adjusted for such items is useful to investors because it enables them to better understand the growth of our business from period-to-period.
The Company defines adjusted EBITDA as net income (loss) before income taxes, net interest expense, depreciation and amortization, equity in net loss of equity-method investees, stock-based compensation, net, impairment of long-lived assets, unrealized currency gains and losses, productivity and transformation costs, proceeds from an insurance claim, gains on sales of businesses, warehouse and manufacturing consolidation and other costs, plant closure related costs, SKU rationalization and inventory write-downs, litigation and related expenses and other adjustments. The Company's management believes that these presentations provide useful information to management, analysts and investors regarding certain additional financial and business trends relating to its results of operations and financial condition. In addition, management uses these measures for reviewing the financial results of the Company as well as a component of performance-based executive compensation.
The Company defines operating free cash flow as cash provided by or used in operating activities from continuing operations (a GAAP measure) less purchases of property, plant and equipment. The Company views operating free cash flow as an important measure because it is one factor in evaluating the amount of cash available for discretionary investments.
|
|||||
Consolidated Balance Sheets |
|||||
(unaudited and in thousands) |
|||||
|
|
||||
ASSETS |
|||||
Current assets: |
|||||
Cash and cash equivalents |
$ 27,523 |
$ 37,771 |
|||
Accounts receivable, net |
166,086 |
170,969 |
|||
Inventories |
292,968 |
248,170 |
|||
Prepaid expenses and other current assets |
55,151 |
95,690 |
|||
Assets held for sale |
71,023 |
8,334 |
|||
Total current assets |
612,751 |
560,934 |
|||
Property, plant and equipment, net |
275,708 |
289,256 |
|||
|
860,347 |
861,958 |
|||
Trademarks and other intangible assets, net |
319,760 |
346,462 |
|||
Investments and joint ventures |
17,899 |
17,439 |
|||
Operating lease right-of-use assets |
89,397 |
88,165 |
|||
Other assets |
23,872 |
24,238 |
|||
Total assets |
$ 2,199,734 |
$ 2,188,452 |
|||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||
Current liabilities: |
|||||
Accounts payable |
$ 184,997 |
$ 171,009 |
|||
Accrued expenses and other current liabilities |
117,352 |
124,045 |
|||
Current portion of long-term debt |
445 |
1,656 |
|||
Liabilities related to assets held for sale |
26,209 |
3,567 |
|||
Total current liabilities |
329,003 |
300,277 |
|||
Long-term debt, less current portion |
289,042 |
281,118 |
|||
Deferred income taxes |
30,985 |
51,849 |
|||
Operating lease liabilities, noncurrent portion |
82,962 |
82,962 |
|||
Other noncurrent liabilities |
31,161 |
28,692 |
|||
Total liabilities |
763,153 |
744,898 |
|||
Total stockholders' equity |
1,436,581 |
1,443,554 |
|||
Total liabilities and stockholders' equity |
$ 2,199,734 |
$ 2,188,452 |
|
|||
Consolidated Statements of Operations |
|||
(unaudited and in thousands, except per share amounts) |
|||
First Quarter |
|||
2021 |
2020 |
||
Net sales |
|
$ 482,076 |
|
Cost of sales |
379,463 |
384,245 |
|
Gross profit |
119,164 |
97,831 |
|
Selling, general and administrative expenses |
79,152 |
80,680 |
|
Amortization of acquired intangible assets |
2,433 |
3,083 |
|
Productivity and transformation costs |
1,802 |
14,175 |
|
Proceeds from insurance claim |
- |
(2,562) |
|
Long-lived asset impairment |
32,497 |
- |
|
Operating income |
3,280 |
2,455 |
|
Interest and other financing expense, net |
2,453 |
6,294 |
|
Other (income) expense, net |
(1,373) |
1,328 |
|
Income (loss) from continuing operations before income taxes and equity in net loss of equity-method investees |
2,200 |
(5,167) |
|
Provision (benefit) for income taxes |
12,962 |
(531) |
|
Equity in net loss of equity-method investees |
19 |
317 |
|
Net loss from continuing operations |
|
$ (4,953) |
|
Net income (loss) from discontinued operations, net of tax |
11,266 |
(102,068) |
|
Net income (loss) |
$ 485 |
|
|
Net (loss) income per common share: |
|||
Basic net loss per common share from continuing operations |
$ (0.11) |
$ (0.05) |
|
Basic net income (loss) per common share from discontinued operations |
0.11 |
(0.98) |
|
Basic net loss per common share |
$ - |
$ (1.03) |
|
Diluted net loss per common share from continuing operations |
$ (0.11) |
$ (0.05) |
|
Diluted net income (loss) per common share from discontinued operations |
0.11 |
(0.98) |
|
Diluted net loss per common share |
$ - |
$ (1.03) |
|
Shares used in the calculation of net (loss) income per common share: |
|||
Basic |
101,558 |
104,225 |
|
Diluted |
101,558 |
104,225 |
|
|||
Consolidated Statements of Cash Flows |
|||
(unaudited and in thousands) |
|||
First Quarter |
|||
2021 |
2020 |
||
CASH FLOWS FROM OPERATING ACTIVITIES |
|||
Net income (loss) |
$ 485 |
|
|
Net income (loss) from discontinued operations |
11,266 |
(102,068) |
|
Net loss from continuing operations |
(10,781) |
(4,953) |
|
Adjustments to reconcile net loss from continuing operations to net cash provided by (used in) operating activities from continuing operations: |
|||
Depreciation and amortization |
13,761 |
13,923 |
|
Deferred income taxes |
(930) |
(4,404) |
|
Equity in net loss of equity-method investees |
19 |
317 |
|
Stock-based compensation, net |
4,367 |
2,737 |
|
Long-lived asset impairment |
32,497 |
- |
|
Other non-cash items, net |
(1,667) |
1,764 |
|
Increase (decrease) in cash attributable to changes in operating assets and liabilities: |
|||
Accounts receivable |
(3,575) |
(853) |
|
Inventories |
(44,962) |
(5,507) |
|
Other current assets |
37,869 |
14,223 |
|
Other assets and liabilities |
(1,541) |
144 |
|
Accounts payable and accrued expenses |
15,612 |
(20,972) |
|
Net cash provided by (used in) operating activities from continuing operations |
40,669 |
(3,581) |
|
CASH FLOWS FROM INVESTING ACTIVITIES |
|||
Purchases of property, plant and equipment |
(12,155) |
(13,164) |
|
Proceeds from sale of businesses and other |
4,427 |
- |
|
Net cash used in investing activities from continuing operations |
(7,728) |
(13,164) |
|
CASH FLOWS FROM FINANCING ACTIVITIES |
|||
Borrowings under bank revolving credit facility |
55,000 |
80,000 |
|
Repayments under bank revolving credit facility |
(47,000) |
(178,500) |
|
Repayments under term loan |
- |
(206,250) |
|
Proceeds from discontinued operations entities |
- |
312,195 |
|
(Repayments) borrowings of other debt, net |
(1,439) |
9 |
|
Share repurchases |
(42,052) |
- |
|
Shares withheld for payment of employee payroll taxes |
(468) |
(312) |
|
Net cash (used in) provided by financing activities from continuing operations |
(35,959) |
7,142 |
|
Effect of exchange rate changes on cash from continuing operations |
2,500 |
(892) |
|
CASH FLOWS FROM DISCONTINUED OPERATIONS |
|||
Cash used in operating activities |
- |
(8,026) |
|
Cash provided by investing activities |
- |
306,420 |
|
Cash used in financing activities |
- |
(306,366) |
|
Effect of exchange rate changes on cash from discontinued operations |
- |
(537) |
|
Net cash flows used in discontinued operations |
- |
(8,509) |
|
Net decrease in cash and cash equivalents |
(518) |
(19,004) |
|
Cash and cash equivalents at beginning of period |
37,771 |
39,526 |
|
Cash and cash equivalents at end of period |
|
$ 20,522 |
|
To reconcile cash and cash equivalents on the Consolidated Balance Sheets to cash and cash equivalents at end of period on the Consolidated Statements of Cash Flows: |
|||
Cash and cash equivalents |
|
$ 20,522 |
|
Cash and cash equivalents classified in assets held for sale |
9,730 |
- |
|
Total cash and cash equivalents shown in the Statement of Cash Flows |
|
$ 20,522 |
|
|||||||
|
|||||||
(unaudited and in thousands) |
|||||||
|
International |
Corporate/Other |
Hain Consolidated |
||||
|
|||||||
Net sales - Q1 FY21 |
$ 280,668 |
$ 217,959 |
$ - |
$ 498,627 |
|||
Net sales - Q1 FY20 |
$ 271,701 |
$ 210,375 |
$ - |
$ 482,076 |
|||
% change - FY'21 net sales vs. FY'20 net sales |
3.3% |
3.6% |
3.4% |
||||
Gross Profit |
|||||||
Q1 FY21 |
|||||||
Gross profit |
$ 75,015 |
$ 44,149 |
$ - |
$ 119,164 |
|||
Non-GAAP adjustments (1) |
933 |
240 |
- |
1,173 |
|||
Adjusted gross profit |
$ 75,948 |
$ 44,389 |
$ - |
$ 120,337 |
|||
Gross margin |
26.7% |
20.3% |
23.9% |
||||
Adjusted gross margin |
27.1% |
20.4% |
24.1% |
||||
Q1 FY20 |
|||||||
Gross profit |
$ 62,361 |
$ 35,470 |
$ - |
$ 97,831 |
|||
Non-GAAP adjustments (1) |
1,725 |
1,076 |
- |
2,801 |
|||
Adjusted gross profit |
$ 64,086 |
$ 36,546 |
$ - |
$ 100,632 |
|||
Gross margin |
23.0% |
16.9% |
20.3% |
||||
Adjusted gross margin |
23.6% |
17.4% |
20.9% |
||||
Operating income (loss) |
|||||||
Q1 FY21 |
|||||||
Operating income (loss) |
$ 33,256 |
$ (15,889) |
$ (14,087) |
$ 3,280 |
|||
Non-GAAP adjustments (1) |
1,488 |
33,194 |
805 |
35,487 |
|||
Adjusted operating income (loss) |
$ 34,744 |
$ 17,305 |
$ (13,282) |
$ 38,767 |
|||
Operating income (loss) margin |
11.8% |
(7.3)% |
0.7% |
||||
Adjusted operating income margin |
12.4% |
7.9% |
7.8% |
||||
Q1 FY20 |
|||||||
Operating income (loss) |
$ 15,132 |
$ 9,107 |
$ (21,784) |
$ 2,455 |
|||
Non-GAAP adjustments (1) |
3,896 |
2,344 |
8,222 |
14,462 |
|||
Adjusted operating income (loss) |
$ 19,028 |
$ 11,451 |
$ (13,562) |
$ 16,917 |
|||
Operating income margin |
5.6% |
4.3% |
0.5% |
||||
Adjusted operating income margin |
7.0% |
5.4% |
3.5% |
(1) See accompanying table "Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Adjusted EPS" |
|
|||||||
Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Adjusted EPS |
|||||||
(unaudited and in thousands, except per share amounts) |
|||||||
First Quarter |
|||||||
2021 GAAP |
Adjustments |
2021 Adjusted |
2020 GAAP |
Adjustments |
2020 Adjusted |
||
Net sales |
$ 498,627 |
$ - |
$ 498,627 |
$ 482,076 |
$ - |
$ 482,076 |
|
Cost of sales |
379,463 |
(1,173) |
378,290 |
384,245 |
(2,801) |
381,444 |
|
Gross profit |
119,164 |
1,173 |
120,337 |
97,831 |
2,801 |
100,632 |
|
Operating expenses (a) |
114,082 |
(32,512) |
81,570 |
83,763 |
(48) |
83,715 |
|
Productivity and transformation costs |
1,802 |
(1,802) |
- |
14,175 |
(14,175) |
- |
|
Proceeds from insurance claims |
- |
- |
- |
(2,562) |
2,562 |
- |
|
Operating income |
3,280 |
35,487 |
38,767 |
2,455 |
14,462 |
16,917 |
|
Interest and other expense (income), net (b) |
1,080 |
1,822 |
2,902 |
7,622 |
(2,659) |
4,963 |
|
Provision (benefit) provision for income taxes |
12,962 |
(4,562) |
8,400 |
(531) |
3,800 |
3,269 |
|
Net (loss) income from continuing operations |
(10,781) |
38,227 |
27,446 |
(4,953) |
13,321 |
8,368 |
|
Net income (loss) from discontinued operations, net of tax |
11,266 |
(11,266) |
- |
(102,068) |
102,068 |
- |
|
Net income (loss) |
485 |
26,961 |
27,446 |
(107,021) |
115,389 |
8,368 |
|
Diluted net (loss) income per common share from continuing operations |
(0.11) |
0.38 |
0.27 |
(0.05) |
0.13 |
0.08 |
|
Diluted net income (loss) per common share from discontinued operations |
0.11 |
(0.11) |
- |
(0.98) |
0.98 |
- |
|
Diluted net (loss) income per common share |
- |
0.27 |
0.27 |
(1.03) |
1.11 |
0.08 |
|
Detail of Adjustments: |
|||||||
Q1 FY21 |
Q1 FY20 |
||||||
Plant closure related costs |
$ 579 |
$ 933 |
|||||
SKU rationalization and inventory write-down |
204 |
(11) |
|||||
Warehouse/manufacturing consolidation and other costs |
390 |
1,879 |
|||||
Cost of sales |
1,173 |
2,801 |
|||||
Gross profit |
1,173 |
2,801 |
|||||
Long-lived asset impairment |
32,497 |
- |
|||||
Plant closure related costs |
15 |
- |
|||||
Litigation and related expenses |
- |
48 |
|||||
Operating expenses (a) |
32,512 |
48 |
|||||
Productivity and transformation costs |
1,802 |
14,175 |
|||||
Productivity and transformation costs |
1,802 |
14,175 |
|||||
Proceeds from insurance claims |
- |
(2,562) |
|||||
Proceeds from insurance claims |
- |
(2,562) |
|||||
Operating income |
35,487 |
14,462 |
|||||
Unrealized currency (gains) losses |
(1,202) |
1,684 |
|||||
Gain on sale of businesses |
(620) |
- |
|||||
Deferred financing cost write-off |
- |
975 |
|||||
Interest and other (income) expense, net (b) |
(1,822) |
2,659 |
|||||
Income tax related adjustments |
4,562 |
(3,800) |
|||||
Provision (benefit) provision for income taxes |
4,562 |
(3,800) |
|||||
Net income from continuing operations |
$ 38,227 |
$ 13,321 |
(a)Operating expenses include amortization of acquired intangibles, selling, general, and administrative expenses and long-lived asset impairment. |
||||||
(b)Interest and other expense (income), net includes interest and other financing expenses, net and other expense, net. |
|
|||||
Adjusted Net Sales Growth |
|||||
(unaudited and in thousands) |
|||||
Q1 FY21 |
|
International |
Hain Consolidated |
||
Net sales - Q1 FY21 |
$ 280,668 |
$ 217,959 |
$ 498,627 |
||
Divestitures and discontinued brands |
(3,379) |
(908) |
(4,287) |
||
Impact of foreign currency exchange |
363 |
(9,886) |
(9,523) |
||
Net sales on a constant currency basis adjusted for divestitures and discontinued brands - Q1 FY21 |
$ 277,652 |
$ 207,165 |
$ 484,817 |
||
Q1 FY20 |
|||||
Net sales Q1 FY20 |
$ 271,701 |
$ 210,375 |
$ 482,076 |
||
Divestitures and discontinued brands |
(19,709) |
(1,612) |
(21,321) |
||
Net sales adjusted for divestitures and discontinued brands - Q1 FY20 |
$ 251,992 |
$ 208,763 |
$ 460,755 |
||
Net sales growth |
3.3% |
3.6% |
3.4% |
||
Impact of foreign currency exchange |
0.1% |
(4.7)% |
(2.0)% |
||
Impact of divestitures and discontinued brands |
6.6% |
0.3% |
3.8% |
||
Net sales growth/(decline) on a constant currency basis adjusted for divestitures and discontinued brands |
10.1% |
(0.8)% |
5.2% |
|
|||
Adjusted EBITDA |
|||
(unaudited and in thousands) |
|||
First Quarter |
|||
2021 |
2020 |
||
Net income (loss) |
$ 485 |
|
|
Net income (loss) from discontinued operations |
11,266 |
(102,068) |
|
Net loss from continuing operations |
|
$ (4,953) |
|
Provision (benefit) for income taxes |
12,962 |
(531) |
|
Interest expense, net |
2,154 |
4,552 |
|
Depreciation and amortization |
13,761 |
13,923 |
|
Equity in net loss of equity-method investees |
19 |
317 |
|
Stock-based compensation, net |
4,367 |
2,737 |
|
Long-lived asset impairment |
32,497 |
- |
|
Unrealized currency (gains) losses |
(1,202) |
1,684 |
|
Productivity and transformation costs |
1,150 |
14,175 |
|
Proceeds from insurance claim |
- |
(2,562) |
|
Gain on sale of businesses |
(620) |
- |
|
Warehouse/manufacturing consolidation and other costs |
390 |
1,879 |
|
Plant closure related costs |
(6) |
832 |
|
SKU rationalization and inventory write-down |
204 |
(11) |
|
Litigation and related expenses |
- |
48 |
|
Adjusted EBITDA |
$ 54,895 |
$ 32,090 |
|
|||||||
Adjusted EBITDA by Segment |
|||||||
(unaudited and in thousands) |
|||||||
|
International |
Corporate/Other |
Hain Consolidated |
||||
Q1 FY21 |
|||||||
Operating income (loss) |
$ 33,256 |
$ (15,889) |
$ (14,087) |
$ 3,280 |
|||
Depreciation and amortization |
4,145 |
8,862 |
754 |
13,761 |
|||
Long-lived asset impairment |
(11) |
32,508 |
- |
32,497 |
|||
Productivity and transformation costs |
554 |
445 |
803 |
1,802 |
|||
Loss (gain) on sale of businesses |
189 |
(1,344) |
535 |
(620) |
|||
Warehouse/manufacturing consolidation and other costs |
200 |
190 |
- |
390 |
|||
Plant closure related costs |
(57) |
51 |
- |
(6) |
|||
SKU rationalization and inventory write-down |
204 |
- |
- |
204 |
|||
Other |
642 |
1,881 |
1,064 |
3,587 |
|||
Adjusted EBITDA |
$ 39,122 |
$ 26,704 |
$ (10,931) |
$ 54,895 |
|||
|
International |
Corporate/Other |
Hain Consolidated |
||||
Q1 FY20 |
|||||||
Operating income (loss) |
$ 15,132 |
$ 9,107 |
$ (21,784) |
$ 2,455 |
|||
Depreciation and amortization |
4,348 |
7,926 |
1,649 |
13,923 |
|||
Productivity and transformation costs |
2,168 |
1,272 |
10,735 |
14,175 |
|||
Proceeds from insurance claim |
- |
- |
(2,562) |
(2,562) |
|||
Warehouse/manufacturing consolidation and other costs |
1,879 |
- |
- |
1,879 |
|||
Plant closure related costs |
37 |
795 |
- |
832 |
|||
SKU rationalization and inventory write-down |
(190) |
179 |
- |
(11) |
|||
Litigation and related expenses |
- |
- |
48 |
48 |
|||
Other |
665 |
432 |
254 |
1,351 |
|||
Adjusted EBITDA |
$ 24,039 |
$ 19,711 |
$ (11,660) |
$ 32,090 |
|
|||||||
Adjusted EBITDA Margin at Constant Currency by Segment |
|||||||
(unaudited and in thousands) |
|||||||
Q1 FY21 |
|
International |
Corporate/Other |
Hain Consolidated |
|||
Adjusted EBITDA - Q1 FY21 |
$ 39,122 |
$ 26,704 |
$ (10,931) |
$ 54,895 |
|||
Impact of foreign currency exchange |
61 |
(1,281) |
- |
(1,220) |
|||
Adjusted EBITDA on a constant currency basis - Q1 FY21 |
$ 39,183 |
$ 25,423 |
$ (10,931) |
$ 53,675 |
|||
Net sales on a constant currency basis - Q1 FY21 |
$ 281,031 |
$ 208,073 |
$ 489,104 |
||||
Adjusted EBITDA margin on a constant currency basis |
13.9% |
12.2% |
11.0% |
|
|||
Operating Free Cash Flow |
|||
(unaudited and in thousands) |
|||
First Quarter |
|||
2021 |
2020 |
||
Net cash provided by (used in) operating activities from continuing operations |
|
$ (3,581) |
|
Purchases of property, plant and equipment |
(12,155) |
(13,164) |
|
Operating free cash flow from continuing operations (1) |
|
|
(1) The increase in operating free cash flow resulted primarily from an improvement in net income adjusted for non-cash charges in the current period and greater cash generation from our working capital accounts. |
View original content to download multimedia:http://www.prnewswire.com/news-releases/hain-celestial-reports-first-quarter-fiscal-year-2021-financial-results-301168985.html
SOURCE
Chris Mandeville and Anna Kate Heller, ICR, 203-682-8304